Immunomedics, Inc. is showing notable market movement today, up 3.5%, or roughly $109.3 million gain.
The company has made notable gains in 5 of the last 11 trading sessions, with 3 of those days occurring consecutively from Mar 01-05.
Immunomedics holds a market capitalization of $3.5 billion and represents 0.6% of the $586.1 billion NASDAQ/NYSE biotechnology industry.
The industry overall is up today by 1.2%, which translates to an increase of roughly $7.1 billion. The industry increases are led by AbbVie Inc., up 1.74%. AbbVie represents 21.0% of the industry, with a market capitalization of $123.1 billion.
Historically, the average daily return for the industry in week #10 has been -0.11%, while the mode daily return is -0.02%.
With a 42stocks weight of 49.4, Immunomedics ranks #1820 against 4169 symbols tracked, and #51 of 311 within the industry. A lower rank is more favorable, while a lower weight is less favorable.